logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
T

Teiji Kuzuya

seoul national university
H指数:35
被引数:4,156

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Biomarker-Based Responder Selection and Early Prediction of Treatment Response in Hepatocellular Carcinoma: Dynamic Changes in Alpha-Fetoprotein and Des-Gamma-Carboxy Prothrombin During Atezolizumab Plus Bevacizumab Therapy

基于生物标志物的应答者选择和治疗反应的早期预测在肝细胞癌中的应用：阿特珠单抗联合贝伐珠单抗治疗期间α-胎儿蛋白和去伽马羧基凝血酶原的动态变化

Cancers 2025, Vol. 17, Page 3891
IF4.4
2025-12-050
OAAI
Teiji Kuzuya; Hisanori Muto; Yoshihiko Tachi; Mariko Kobayashi; Hijiri Sugiyama; Mizuki Ariga; Sayaka Morisaki; Gakushi Komura; Takuji Nakano; Hiroyuki Tanaka; Kazunori Nakaoka; Eizaburo Ohno; Kohei Funasaka; Mitsuo Nagasaka; Ryoji Miyahara; Yoshiki Hirooka
Atezolizumab Plus Bevacizumab for TACE-Unsuitable Intermediate-Stage HCC Beyond Up-To-7 Criteria: Final Analysis of REPLACEMENT

阿替利珠单抗联合贝伐珠单抗用于不适合TACE治疗的超出Up-To-7标准的中间阶段肝癌：REPLACEMENT研究的最终分析

Liver International
IF5.2
2025-11-030
OAAI
Kazuomi Ueshima; Kaoru Tsuchiya; Tatsuya Yamashita; Shigeo Shimose; Kazushi Numata; Yuzo Kodama; Shinji Itoh; Yasuhito Tanaka; Hidekatsu Kuroda; Kazuyoshi Ohkawa; Teiji Kuzuya; Masafumi Ikeda; Youhei Kooka; Hiroshi Aikata; Atsushi Hiraoka; Michihisa Moriguchi; Ryosuke Tateishi; Sadahisa Ogasawara; Kouji Yamamoto; Masatoshi Kudo
Clinical Outcomes of Reduced-Dose Cabozantinib as Third- or Later-Line Therapy After Immune Checkpoint Inhibitors in Advanced Hepatocellular Carcinoma: A Real-World Study

在免疫检查点抑制剂后，晚期肝细胞癌患者接受减量卡博赞替尼作为三线或更后线治疗的临床结局：一项真实世界研究

HEPATOLOGY RESEARCH
IF3.4
2025-11-010
OAAI
Kuzuya, Teiji; Muto, Hisanori; Tachi, Yoshihiko; Ariga, Mizuki; Morisaki, Sayaka; Komura, Gakushi; Nakano, Takuji; Tanaka, Hiroyuki; Nakaoka, Kazunori; Ohno, Eizaburo; Funasaka, Kohei; Nagasaka, Mitsuo; Miyahara, Ryoji; Hirooka, Yoshiki
Contrast-enhanced ultrasound imaging characteristics of intrahepatic cholangiocarcinoma with actionable gene variants detected by comprehensive cancer gene panel testing

肝内胆管癌携带可通过综合癌症基因-panel检测到的可操作基因变异的增强超声成像特征

international journal of oncology
IF2.8
2025-05-050
PRE
Nakaoka, Kazunori; Ohno, Eizaburo; Yamada, Seiji; Kuzuya, Teiji; Sudo, Tamotsu; Ueno, Sayaka; Tanaka, Hiroyuki; Sasaki, Yutaka; Miyahara, Ryoji; Hashimoto, Senju; Hirooka, Yoshiki
Protocol of the IMPACT study: randomized, multicenter, phase 3 study evaluating the efficacy of immunotherapy (Atezolizumab) plus anti-VEGF therapy (Bevacizumab) in combination with transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma
BMC CANCER
IF3.4
2025-03-110
OAAI
Kodama, Yoshihisa; Ueshima, Kazuomi; Moriguchi, Michihisa; Inaba, Yoshitaka; Yamashita, Tatsuya; Iwamoto, Hideki; Ueno, Makoto; Ogasawara, Sadahisa; Kuzuya, Teiji; Kodama, Takahiro; Sato, Yozo; Tada, Toshifumi; Tsuchiya, Kaoru; Nishiofuku, Hideyuki; Yamakado, Koichiro; Sone, Miyuki; Ikeda, Masafumi; Takehara, Tetsuo; Hamano, Tetsutaro; Kudo, Masatoshi
Final analysis of the REPLACEMENT study: a phase II study of atezolizumab plus bevacizumab (atezo plus bev) for patients (pts) with Transcatheter arterial chemoembolization (TACE)-unsuitable intermediate-stage hepatocellular carcinoma (HCC) beyond the up-to-seven criteria

REPLACEMENT研究的最终分析：一项关于阿替利珠单抗联合贝伐珠单抗（atezo plus bev）治疗经肝动脉化疗栓塞（TACE）不适宜的超出“七例标准”的中期肝细胞癌（HCC）患者的II期研究

ANNALS OF ONCOLOGY
IF65.4
2024-12-011
PRE
Yamashita, T.; Ueshima, K.; Tsuchiya, K.; Kato, N.; Shimose, S.; Numata, K.; Kodama, Y.; Ohkawa, K.; Kuzuya, T.; Ikeda, M.; Kooka, Y.; Aikata, H.; Hiraoka, A.; Moriguchi, M.; Fujiwara, K.; Suda, G.; Mochida, S.; Ogasawara, S.; Yamamoto, K.; Kudo, M.
Ramucirumab for advanced hepatocellular carcinoma in the current real world: a Japanese single-arm study post-REACH-2 (The R-evolution study)
INVESTIGATIONAL NEW DRUGS
IF2.7
2024-06-060
OAAI
Kobayashi, Kazufumi; Ogasawara, Sadahisa; Itobayashi, Ei; Okubo, Tomomi; Itokawa, Norio; Nakamura, Kazuyoshi; Moriguchi, Michihisa; Watanabe, Shunji; Ikeda, Masafumi; Kuroda, Hidekatsu; Kawaoka, Tomokazu; Hiraoka, Atsushi; Yasui, Yutaka; Kuzuya, Teiji; Sato, Rui; Kanzaki, Hiroaki; Koroki, Keisuke; Inoue, Masanori; Nakamura, Masato; Kiyono, Soichiro; Kanogawa, Naoya; Kondo, Takayuki; Nakamoto, Shingo; Ozawa, Yoshihito; Tsuchiya, Kaoru; Atsukawa, Masanori; Aikata, Hiroshi; Aramaki, Takeshi; Oka, Shiro; Morimoto, Naoki; Kurosaki, Masayuki; Itoh, Yoshito; Izumi, Namiki; Kato, Naoya
Safety and efficacy of atezolizumab (Atezo) plus bevacizumab (Bev) in Japanese patients (pts) with unresectable hepatocellular carcinoma (uHCC): Preliminary analysis of a prospective, multicenter, observational study (ELIXIR)
ANNALS OF ONCOLOGY
IF65.4
2023-11-010
OA
Kuzuya, T.; Yamashita, T.; Takehara, T.; Aikata, H.; Kato, N.; Hiasa, Y.; Nakamura, S.; Morimoto, N.; Moriguchi, M.; Ikeda, M.; Inoue, J.; Tani, J.; Ueno, Y.; Chayama, K.; Tateishi, R.; Kawamura, Y.; Furuse, J.; Kudo, M.; Yamamoto, K.; Kokudo, N.
IMPACT: Randomized, multicenter, phase III study evaluating the efficacy of immunotherapy (atezolizumab) plus anti-VEGF therapy (bevacizumab) in combination with transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma (HCC)
ANNALS OF ONCOLOGY
IF65.4
2023-11-012
PRE
Yamashita, T.; Inaba, Y.; Ikeda, M.; Sone, M.; Yamakado, K.; Nishiofuku, H.; Tsuchiya, K.; Tada, T.; Sato, Y.; Kodama, T.; Kuzuya, T.; Ogasawara, S.; Ueno, M.; Iwamoto, H.; Moriguchi, M.; Ueshima, K.; Kodama, Y.; Takehara, T.; Hamano, T.; Kudo, M.
A Phase 2, Prospective, Multicenter, Single-arm Trial of Transarterial Chemoembolization Therapy in Combination Strategy with Lenvatinib in Patients with Unresectable Intermediate-stage Hepatocellular Carcinoma: TACTICS-L Trial
LIVER CANCER
IF9.1
2023-06-0536
OAAI
Kudo, Masatoshi; Ueshima, Kazuomi; Saeki, Issei; Ishikawa, Toru; Inaba, Yoshitaka; Morimoto, Naoki; Aikata, Hiroshi; Tanabe, Nobukazu; Wada, Yoshiyuki; Kondo, Yasuteru; Tsuda, Masahiro; Nakao, Kazuhiko; Ito, Takanori; Hosaka, Tetsuya; Kawamura, Yusuke; Kuzuya, Teiji; Nojiri, Shunsuke; Ogawa, Chikara; Koga, Hironori; Hino, Keisuke; Ikeda, Masafumi; Moriguchi, Michihisa; Hisai, Takashi; Yoshimura, Kenichi; Furuse, Junji; Arai, Yasuaki
Final Results of TACTICS: A Randomized, Prospective Trial Comparing Transarterial Chemoembolization Plus Sorafenib to Transarteria Chemoembolization Alone in Patients with Unresectable Hepatocellular Carcinoma
LIVER CANCER
IF9.1
2022-02-1075
OAAI
Kudo, Masatoshi; Ueshima, Kazuomi; Ikeda, Masafumi; Torimura, Takuji; Tanabe, Nobukazu; Aikata, Hiroshi; Izumi, Namiki; Yamasaki, Takahiro; Nojiri, Shunsuke; Hino, Keisuke; Tsumura, Hidetaka; Kuzuya, Teiji; Isoda, Norio; Moriguchi, Michihisa; Aino, Hajime; Ido, Akio; Kawabe, Naoto; Nakao, Kazuhiko; Wada, Yoshiyuki; Ogasawara, Sadahisa; Yoshimura, Kenichi; Okusaka, Takuji; Furuse, Junji; Kokudo, Norihiro; Okita, Kiwamu; Johnson, Philip James; Arai, Yasuaki

研究方向

暂未获取到该数据
T
Takashi Honda
H 指数:53论文数:714被引数:1.3万
M
Masatoshi Ishigami
H 指数:41论文数:388被引数:7,398
Y
Yoji Ishizu
H 指数:26论文数:180被引数:1,976
Y
Yoshiki Hirooka
H 指数:59论文数:814被引数:1.3万
K
Kazuhiko Hayashi
H 指数:42论文数:430被引数:7,134
H
Hidemi Goto
H 指数:70论文数:962被引数:1.8万
T
Tetsuya Ishikawa
H 指数:46论文数:355被引数:8,989
T
Takashi Kumada
H 指数:70论文数:719被引数:2.1万
T
Takanori Ito
H 指数:31论文数:221被引数:3,290
H
Hidenori Toyoda
H 指数:75论文数:783被引数:2.6万